US Patent Issued to Mylan Pharmaceuticals on July 14 for "Solid oral pharmaceutical compositions including alkyl 3,4,5-trihydroxybenzoate as a nitrosamine inhibitor" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,420, issued on July 14, was assigned to Mylan Pharmaceuticals Inc. (Morgatown, W.va.).

"Solid oral pharmaceutical compositions including alkyl 3,4,5-trihydroxybenzoate as a nitrosamine inhibitor" was invented by John D. Kirsch (Waynesburg, Pa.) and Ross A. Friedman (Washington, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a solid oral pharmaceutical composition that includes: (a) an active pharmaceutical ingredient; (b) a nitrosamine inhibitor that includes linear or branched C1-C10 alkyl 3,4,5-trihydroxybenzoate; and (c) a pharmaceutically acceptable excipient. At least one of: (i) the active pharmaceutical in...